No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
EFTR eFFECTOR Therapeutics
- 0.001
- +0.000+200.00%
15min DelayTrading Jan 2 09:30 ET
2.82KMarket Cap0.00P/E (TTM)
0.001High0.001Low100Volume0.001Open0.000Pre Close0.06Turnover0.00%Turnover Ratio0.00P/E (Static)4.70MShares17.75052wk High0.00P/B2.80KFloat Cap0.00052wk Low--Dividend TTM4.66MShs Float1010.500Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Kaskela Law LLC Announces Investigation of EFFECTOR Therapeutics, Inc. (EFTR) and Encourages Former EFFECTOR Employees to Contact the Firm
Express News | EFFECTOR Therapeutics - Oxford Notice Indicates Obligations Under Loan and Security Agreement Shall Accrue Interest at Default Rate
Express News | EFFECTOR Therapeutics Inc - Oxford Notice Indicates That All Obligations Are Now Immediately Due and Payable
Express News | EFFECTOR Therapeutics- Got Notice From Oxford Finance, Events of Default Occurred With Respect to Loan,Security Agreement Dated as of March 19, 2021
EFFECTOR Therapeutics Declared in Default on $75M Oxford Finance Loan
Top Midday Decliners
Heat List
US
Overall
Symbol
Price
% Chg
No Data